See also this year's filing and all EDGAR filings for this company.
PDF Report 0001131324_2012_Genomic_Health_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | No stock price available | subcommand.plot | {} |
| info | NetIncome node detected by tax heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001131324')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001131324, Genomic Health INC
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 0 |
| 1 | AssetsNonCurrent | 4,560,000 |
| 2 | AssetsCurrent | 128,995,000 |
| 3 | PropertyPlantAndEquipment | 9,443,000 |
| 4 | remainder_Assets | 0 |
| 5 | LongTermLiabilities | 0 |
| 6 | LiabilitiesCurrent | 26,139,000 |
| 7 | remainder_Liabilities | 0 |
| 8 | LaborExpense | 0 |
| 9 | CostOfGoodsAndServicesSold | 0 |
| 10 | GeneralAndAdministrativeExpense | 40,543,000 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 0 |
| 13 | DepreciationDepletionAndAmortization | 0 |
| 14 | SellingAndMarketingExpense | 83,613,000 |
| 15 | ResearchAndDevelopmentExpense | 39,864,000 |
| 16 | remainder_Expenses | 34,261,000 |
| 17 | remainder_Revenues | 206,111,000 |
| 18 | remainder_NetIncome | 16,000 |
| 19 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 142,998,000 |
| 1 | Liabilities | 26,139,000 |
| 2 | Expenses | 198,281,000 |
| 3 | Revenues | 206,111,000 |
| 4 | StockholdersEquity | 116,859,000 |
| 5 | NetIncome | 7,846,000 |
| 6 | ComprehensiveNetIncome | 7,846,000 |
| 7 | BaseVar | 286,772,500 |
| 8 | EconomicCapitalRatio | 3.93 |
Edgar->Model Mapping
Feature Distribution
